The dissertation termed "Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors" studied 242 small molecule inhibitors currently tested in clinical trials and revealed the target landscape of small molecule inhibitors with the use of chemical proteomics. The award winning thesis offers new insights into inhibitor selectivity and the druggable kinome. The results of the study have recently been published in Science (read publication here).
The "Walther und Christine Richtzenhain-Stiftung" awards the "Richtzenhain-Preis" to outstanding dissertations focussing on translational cancer research and the transfer of research results to clinical applications.